Cheryl Wei

2.6k total citations · 1 hit paper
14 papers, 1.9k citations indexed

About

Cheryl Wei is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cheryl Wei has authored 14 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cheryl Wei's work include Diabetes Treatment and Management (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Lipoproteins and Cardiovascular Health (4 papers). Cheryl Wei is often cited by papers focused on Diabetes Treatment and Management (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Lipoproteins and Cardiovascular Health (4 papers). Cheryl Wei collaborates with scholars based in United States, United Kingdom and Denmark. Cheryl Wei's co-authors include Udaya S. Tantry, Kevin P. Bliden, Robert F. Storey, Paul A. Gurbel, Kathleen Butler, Renli Teng, Mark J. Antonino, Arun Karunakaran, Shankar B. Patil and Gary S. Ledley and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Cheryl Wei

14 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

2009 794 citations Paul A. Gurbel, Kevin P. Bliden et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl Wei United States	10	1.4k	809	557	389	145	14	1.9k
Fabiana Rollini United States	29	2.2k 1.5×	1.1k 1.4×	602 1.1×	315 0.8×	142 1.0×	112	2.5k
Christian M. Hackeng Netherlands	17	1.7k 1.2×	783 1.0×	476 0.9×	307 0.8×	261 1.8×	40	2.0k
Francesco Franchi United States	31	2.4k 1.6×	1.2k 1.5×	648 1.2×	342 0.9×	156 1.1×	104	2.8k
Delphine Brugier France	13	1.1k 0.8×	570 0.7×	317 0.6×	250 0.6×	186 1.3×	35	1.5k
Olivier Barthélémy France	23	2.0k 1.4×	1.1k 1.3×	431 0.8×	335 0.9×	144 1.0×	76	2.5k
Oscar Ö. Braun Sweden	23	1.6k 1.1×	724 0.9×	389 0.7×	234 0.6×	154 1.1×	64	2.5k
Kathleen Butler United States	25	2.3k 1.6×	1.0k 1.3×	917 1.6×	357 0.9×	232 1.6×	67	3.1k
Christoph Varenhorst Sweden	23	1.8k 1.3×	912 1.1×	437 0.8×	227 0.6×	177 1.2×	48	2.1k
David S. Small United States	28	1.9k 1.3×	924 1.1×	526 0.9×	367 0.9×	382 2.6×	66	2.4k
Julia Stegherr Germany	11	1.5k 1.0×	717 0.9×	383 0.7×	386 1.0×	333 2.3×	11	1.8k

Countries citing papers authored by Cheryl Wei

Since Specialization

Citations

This map shows the geographic impact of Cheryl Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Wei more than expected).

Fields of papers citing papers by Cheryl Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Wei. The network helps show where Cheryl Wei may publish in the future.

Co-authorship network of co-authors of Cheryl Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Wei. A scholar is included among the top collaborators of Cheryl Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Wei. Cheryl Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bailey, Clifford J., Stefano Del Prato, Cheryl Wei, Daniel Reyner, & Gabriela Luporini Saraiva. (2019). Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes. Diabetes Obesity and Metabolism. 21(11). 2564–2569. 9 indexed citations

Sjöstrand, Mikaela, Cheryl Wei, W. James Cook, et al.. (2017). Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials. Diabetes Therapy. 8(3). 587–599. 8 indexed citations

Perl, Shira, W. James Cook, Cheryl Wei, Peter Öhman, & Boaz Hirshberg. (2016). Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin. Clinical Therapeutics. 38(12). 2578–2588. 5 indexed citations

Mosenzon, Ofri, Gil Leibowitz, Deepak L. Bhatt, et al.. (2016). Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial. Diabetes Care. 40(1). 69–76. 202 indexed citations

Perl, Shira, W. James Cook, Cheryl Wei, Nayyar Iqbal, & Boaz Hirshberg. (2016). Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment. Diabetes Therapy. 7(3). 527–535. 3 indexed citations

Birmingham, Bruce K., Sarah R. Bujac, Robert Elsby, et al.. (2015). Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?. European Journal of Clinical Pharmacology. 71(3). 341–355. 120 indexed citations

Mosenzon, Ofri, Cheryl Wei, Jaime A. Davidson, et al.. (2015). Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial. Diabetes Care. 38(11). 2142–2150. 54 indexed citations

Husted, Steen, Robert F. Storey, Kevin P. Bliden, et al.. (2012). Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Stable Coronary Artery Disease. Clinical Pharmacokinetics. 51(6). 397–409. 47 indexed citations

Bliden, Kevin P., Udaya S. Tantry, Robert F. Storey, et al.. (2011). The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies. American Heart Journal. 162(1). 160–165. 62 indexed citations

10.

Storey, Robert F., Kevin P. Bliden, Shankar B. Patil, et al.. (2010). Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study. Journal of the American College of Cardiology. 56(3). 185–193. 133 indexed citations

11.

Gurbel, Paul A., Kevin P. Bliden, Kathleen Butler, et al.. (2010). Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies. Circulation. 121(10). 1188–1199. 330 indexed citations

12.

Tantry, Udaya S., Kevin P. Bliden, Cheryl Wei, et al.. (2010). First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel. Circulation Cardiovascular Genetics. 3(6). 556–566. 127 indexed citations

13.

Husted, Steen, Paul A. Gurbel, Robert F. Storey, et al.. (2009). Abstract 5494: Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Coronary Artery Disease. Circulation. 120(suppl_18). 3 indexed citations

14.

Gurbel, Paul A., Kevin P. Bliden, Kathleen Butler, et al.. (2009). Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Circulation. 120(25). 2577–2585. 794 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact